Fibroin, the protein of silk, and hydrolyzed fibroin have recently been described to enhance insulin sensitivity and glucose metabolism in 3T3-L1 adipocytes. Here, we report that a series of synthetic peptides derived from the fibroin sequence have enhancing effects on glucose transport in normal and insulin-resistant 3T3-L1 cells. We observed that, among several enzymatic hydrolysates of fibroin, the chymotryptic and peptic hydrolysates were significantly more effective than others in augmenting insulin-stimulated glucose uptake in both cells. We synthesized several peptides of repetitive sequences in fibroin. Treatment with synthesized hexapeptides enhanced insulin-stimulated glucose uptake more than tri-, tetra-or pentapeptides. Among those, the effect of Gly-Ala-Gly-Ala-Gly-Tyr (GAGAGY) was most robust, and especially its activity of blocking off the chronic-insulin-induced loss of insulin-stimulated uptake was remarkable. Data reveal that the residues of tyrosine situated at the ends of the peptides play a critical role for exerting their activities. We demonstrate that the insulin-sensitizing effect of GAGAGY is due to enhancement of phosphoinositide 3-kinase (PI 3-K) signaling pathway. The GAGAGY-induced insulin-stimulated glucose uptake was sensitive to inhibition of PI 3-K by wortmannin. Phosphorylation of Akt was also elevated in GAGAGY-treated cells. Furthermore, GAGAGY significantly increased insulin-induced glucose transporter 4 (GLUT4) translocation without affecting the synthesis of GLUT4. Our findings suggest that fibroin-derived peptides such as GAGAGY could be considered as novel insulin-sensitizing agents with an activity of blocking the development of insulin resistance.
Insulin resistance, an impaired biological response to insulin, is known to play a key role in the development of type 2 diabetes.
1) Impaired insulin action in target tissue such as muscle and fat causes a counter action by insulin hypersecretion and subsequently b-cell failure, resulting in hyperglycemia.
2) For normal glucose homeostasis, the insulin-regulated glucose transporter 4 (GLUT4) in muscle and fat cells is required to reduce plasma glucose level. 3) In response to acute insulin stimulation, GLUT4 translocates from an intracellular location to the plasma membrane, where it facilitates glucose uptake. 4) Numerous studies have shown that phosphoinositide 3-kinase (PI 3-K) activation provides an essential signal for the stimulation of GLUT4 translocation. 5) Downstream targets of PI 3-K that have been implicated in signaling are 3-phosphoinositide-dependent protein kinase (PDK1), 6) Akt, 7) and atypical protein kinase C (PKC)z/l. 8) Enhancing insulin sensitivity is the most important goal of antidiabetic agents for treatment of type 2 diabetes. 9 ) Both pharmacologic and nutritional supplements can be used to sensitize insulin action for GLUT4 translocation. 10, 11) The present study set out to test whether the sensitizing effect of peptides derived from fibroin, the major protein in silk, on insulin action in 3T3-L1 adipocytes.
Fibroin that makes up the cocoon of the Bombyx mori caterpillar consists of two polypeptide chains, heavy (H) and light (L) chains of 391 kDa and 25 kDa, respectively, linked by a disulfide bridge. 12) Fibroin is rich in Gly and Ala residues, permitting a close packing of b sheets, which are predominant in polypeptide chains. The heavy chain contains 5263 residues, composed of 45.9% Gly, 30.3% Ala, 12.1% Ser, 5.3% Tyr, 1.8% Val, and only 4.7% of the other 15 amino acid types. The complete sequence reveals low-complexity crystalline domains made up of Gly-X dipeptide repeats. Residue X is Ala in 64% of the repeats, Ser in 22%, Tyr in 10%, and Val in 3% of the repeats. From these amino acids, two repetitive units predominate: the classical repeat known from earlier work, GAGAGS (423 copies), and GAGAGY (120 copies) which together comprise 72% of the low complexity region. Four other frequently observed repetitive units include GAGYGA (39 copies), GAGVGA (27 copies), GAGAGA (27 copies) and GAGVGY (10 copies).
Recent studies have shown that fibroin, the protein of silk, has specific biological effects. Fibroin reduced blood cholesterol level in rats, 13) and a sulfated peptide derived from fibroin showed an anti-human immunodeficiency virus activity in vitro. 14) In addition, fibroin peptides were shown to prevent DNA damage. 15) Blood glucose lowering effect in ob/ob mice fed with a fibroin hydrolysate was also demonstrated by Nahm and Oh. 16 ) Previously, we reported that fibroin protein and hydrolysates enhance insulin sensitivity and reverses insulin resistance in 3T3-L1 adipocytes. 17) Fibroin hydrolysates were also shown to sensitize insulin action in rat-1 fibroblast over-expressing wild-type human insulin receptors (Hirc-B cells) via mitogen-activated protein kinase (MAPK) pathway. 18) In this study, we observed that hexapeptides derived from fibroin not only enhance insulin-stimulated glucose uptake in 3T3-L1 adipocytes but block the development of insulinresistance in cells exposed to chronic insulin. To explore the mechanism underlying this insulin-sensitizing activity, the effects of the peptides on Akt phosphorylation and GLUT4 translocation was also assessed. 19) To induce insulin resistance, cells were chronically exposed to insulin (10 nM) for 12 h in the presence or absence of peptides. Before the glucose transport assay or in the subcellular fractionation studies, cells were washed 3 times with 3.0 ml Krebs Ringer phosphate buffer (KRP) containing glucose (5 mM) and bovine serum albumin (BSA; 1 g/l) at 40-min intervals over a 2-h period. 3T3-L1 adipocytes were treated or not with peptides at specific concentrations (1-10 mM) for the times noted in the figure legends. DMSO was used as vehicle for untreated cells.
MATERIALS AND METHODS

Materials
Preparation of Enzymatic Hydrolysates of Fibroin Fibroin was prepared from cocoons of the silkworm, Bombyx mori, as previously described. 17) Briefly, 50 g of cocoons were cut into small pieces and boiled in 2.5 l of 5% (w/v) Na 2 CO 3 for 1 h and then filtered through filter paper to remove sericin, the other major silk protein. The residue which is mainly fibroin was solubilized by heating in a solution containing 226.4 g CaCl 2 , 346 g distilled water and 280 ml ethanol at 90°C for 1 h. The solution was clarified by centrifugation at 15300ϫg for 20 min, followed by dialysis against distilled water for 2 d and then lyophilized. The powder was dissolved in enough amount of distilled water and further purified by repeating the same dialysis and lyophilization twice.
Purified fibroin was treated with several proteases to produce peptides. The proteases used were a-chymotrypsin (from bovine pancreas, Ն40 units/mg protein using N-benzoyl-L-tyrosine ethyl ester as substrate), pepsin (from porcine gastric mucosa, 600-1800 units/mg protein using hemoglobin as substrate), trypsin (from bovine pancreas, Ն6000 units/mg protein using N-benzoyl-L-arginine ethyl ester as substrate), and subtilisin (of Bacillus licheniformis, 7-15 units/mg protein using casein as substrate). Proteolytic reactions were carried out for 2 h by adding a protease at the concentrations of 0.01 % (w/w) with optimal conditions of each protease. Samples withdrawn at 20-min intervals over 2-h from each proteolytic mixture were immediately heated in a boiling water bath for 10 min and followed by centrifugation to remove protease and unhydrolyzed fibroin. Concentration of peptide produced in each supernatant was measured by Lowry method to check the degree of hydrolysis, and the hydrolysates finally obtained were lyophilized for treatment to cells.
Peptide Synthesis Peptides were synthesized using automated solid-phase synthesis via the Fmoc (9-fluorenylmethyloxycarbonyl) protection chemistry according to Atherton and Sheppard 20) and purified by reverse phase HPLC using a Capcell Pak C-18 column and a two-solvent system, 0.1% trifluoroacetic acid (TFA)/H 2 O-0.1% TFA/acetonitrile, with a 10 to 70% gradient. The identity of each peptide was confirmed by mass analysis using LC/MS. Glucose Transport Assay Cytochalasin B-inhibitable glucose transport was assayed as previously described by Thomson et al. 21) with some modifications. Briefly, 3T3-L1 adipocytes were exposed to fibroin hydrolysate or peptides in complete DMEM containing 10% FBS for 24 h. Cell monolayers were rapidly washed in KRP at pH 7.4 and incubated with or without 20 mM cytochalasin B for 10 min at 37°C. Insulin (100 nM) was added or not for 10 min, and then [ 3 H]2-deoxyglucose (0.2 mM, 0.2 mCi) was added for an additional 10 min. Glucose uptake was terminated with 3 washes of icecold phosphate buffered saline (PBS). Cells were dissolved in 0.1% sodium dodecyl sulfate (SDS) and counted for radioactivity.
Western Blot Analysis For the detection of Akt, phospho-Akt and GLUT4, the Western blotting procedure was described previously 21, 22) with some modifications. Briefly, cells were rinsed with ice-cold PBS and solubilized in a lysis buffer containing 50 mM N-(2-hydroxyethyl)piperazine-N Ј-2-ethanesulfonic acid (HEPES), 150 mM NaCl, 10 mM ethylenediaminetetraacetic acid (EDTA), 0.5% Triton X-100, 5% glycerol, 0.25% Nonidet P-40, 1 mM phenylmethylsulphonyl fluoride (PMSF), 1 mg/ml aprotinin, 1 mg/ml leupeptin, 100 mM NaF and 1 mM Na 3 VO 4 (pH 7.4) and incubated for 30 min at 4°C. The whole-cell lysates were centrifuged at 4°C for 10 min to remove the insoluble materials. The proteins in the supernatants were separated by 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes. After blocking with Tris-buffered saline (TBS)-T (10 mM Tris, 150 mM NaCl, 0.05% Tween-20, pH 7.6) containing 5% nonfat milk for 1 h at room temperature, the membranes were incubated with the appropriate antibodies. The proteins were visualized by enhanced chemiluminescence using horseradish peroxidase-conjugated antirabbit or mouse IgG. Densitometric analysis of the bands was performed using AlphaImager 2200 (Alpha Innotech Inc., San Leandro, CA, U.S.A.) and analyzed by AlphaEase FC software (Alpha Innotech Inc.). Subcellular Fractionation Total membranes were prepared as described by Kitzman et al. 23) and subcellular membranes were isolated from cells as previously described. 24) Proteins were separated by SDS-PAGE and transferred to nitrocellulose for Western blot analysis.
Statistical Analysis Numerical data are reported as meansϮS.E.M. with the number of replicates indicated in the figure legends. Each graphical point represents an independent data set whether assayed for time or treatment. Data were analyzed by the ANOVA procedure of Statistical Analysis System (SAS Institute, 1999-2001). Significant differences between groups were determined using Duncan's multiple range tests at the pϽ0.05 or pϽ0.01 level.
RESULTS
Effect of Fibroin Hydrolysates on Glucose Uptake in
Normal and Insulin Resistant 3T3-L1 Adipocytes Our previous study showed that preparations of fibroin including fibroin protein (FP), acid hydrolysate of fibroin (FH), and a peptide fraction (FIII) isolated from the hydrolysate significantly enhanced basal and insulin-stimulated glucose uptake in 3T3-L1 adipocytes. 17) In this study, we accessed the effect of enzymatic fibroin hydrolysates obtained by hydrolyzing fibroin with trypsin, pepsin, chymotrypsin or subtilisin (of Bacillus licheniformis). For all proteases, the maximum degree of hydrolysis was achieved within 2-h proteolytic reaction (data not shown) and we used each of 2-h proteolytic hydrolysates for allowing maximized degradation to produce fibroin-derived peptides. We observed that exposure of cells to each enzymatic hydrolysate (1 mg/ml) increased insulinstimulated glucose uptake significantly higher than other fibroin preparations (Table 1 ). In particular, the chymotryptic and peptic hydrolysates showed significantly greater effects than other hydrolysates. The effect of chymotryptic hydrolysate was slightly higher than that of peptic hydrolysate, but the difference was statistically insignificant. In insulin-resistant cells that were chronically exposed to a lower concentration of insulin (10 nM), again all enzymatic hydrolysates significantly prevented the loss of insulin-stimulated glucose transport. Among those, chymotryptic hydrolysate was also most effective in the effect of reversing insulin resistance. Figure 1 illustrates the comparison between the effects of chymotryptic hydrolysate and a synthesized hexapeptide Gly-Ala-Gly-Ala-Gly-Tyr (GAGAGY) deduced from fibroin sequence on glucose uptake in normal and insulin-resistant 3T3-L1 cells. GAGAGY is as an alternate form of the repeating hexapeptide in fibroin (see details below) and we compared its effect on glucose uptake with that of chymotryptic hydrolysate. As described in Table 1 , treatment of chymotryptic hydrolysate enhanced insulin-stimulated glucose uptake in normal and insulin-resistant cells by 25.5Ϯ2.8% and 29.3Ϯ3.2% over control, respectively. Interestingly, GAGAGY was more effective than chymotryptic hydrolysate, although both increased the rate of uptake with statistical significance. It was also shown in Fig. 1 that chymotryptic hydrolysate and GAGAGY increased basal glucose uptake as well (statistical significance not shown). The enhancing effects on basal uptake in insulin-resistant cells were higher than in normal cells.
Effect of Fibroin-derived Synthetic Peptides on InsulinStimulated Glucose Uptake in 3T3-L1 Cells Next, we synthesized hexapeptides including GAGAGS, GAGAGY, GAGYGA, GAGAGA, GAGVGA and GAGVGY, the sequences of which are known to appear repeatedly in fibroin molecule to test the activity on insulin-stimulated glucose uptake. The concentration of peptide or peptide mixture added to the medium was fixed at 1 mg/ml, which was determined from dose-dependent profile of insulin-stimulated glucose uptake in GAGAGY-treated cells. At the concentration range of 0.005-5 mg/ml, GAGAGY induced a concentration-dependent increase in the glucose uptake, with the maximal enhancement being observed at 1-5 mg/ml (data not shown). As shown in Table 2 , exposure to GAGAGY and GAGVGY increased glucose uptake more than 30% over control. With treatment of GAGAGS, GAGYGA, GAGAGA or GAGVGA, insulin-stimulated glucose uptake was increased to 12-19% over control, but which were significantly lower than those with GAGAGY or GAGVGY.
To determine their combined impact on glucose transport, mixtures of two-hexapeptides combination were treated to 3T3-L1 adipocytes to be examined for insulin-stimulated glucose uptake. Results showed that the enhancing activities of mixtures were similar to the additives of activities for independent treatment of each peptide, indicating that combined two or three hexapeptides did not enhance synergistically ( Table 2) .
Effect of Peptides Containing Terminal Tyrosine Residue on Glucose Uptake in 3T3-L1 Adipocytes
To confirm the effect of terminal tyrosine residue on glucose uptake enhancement, we synthesized tri-, tetra-, penta-and hexapeptides with or without terminal tyrosine residue including AGA, GAG, AGY, GYGA, GAGA, GAGS, GAGY, AGAGS, GAGAG, AGYGA, AGAGY and YGAGAG, all of which appear repeatedly in fibroin. To our surprise, consistently with the case of hexapeptides (Table 2) , tetra-and pentapeptides with terminal tyrosine showed significantly higher enhancing activities than those without terminal tyrosine in the same length (Table 3 ). In addition, the activities increased in accordance with peptide length. However, there was no significant difference of activity between N-terminal-(YGA-GAG) and C-terminal-tyrosine hexapeptides (GAGAGY).
We next evaluated the enhancing effects of penta-and Cells were exposed to 1 mg/ml CH (chymotryptic hydrolysate of fibroin) or GAGAGY for 24 h in the absence or presence of chronic exposure to insulin (10 nM) for the final 12 h, then washed three times in KRP containing 0.5% BSA at 40 min-intervals over 2 h at 37°C. Insulin (100 nM) was added or not for 10 min. hexapeptides with terminal tyrosine, YGAGA, AGAGY, YGAGAG and GAGAGY, on glucose uptake in normal and insulin-resistant cells. As shown in Fig. 2 , both of basal and insulin-stimulated glucose uptake were significantly elevated in both of normal and insulin-resistant cells by exposure to all peptides tested. Results were distinguished by their effects on acute insulin-stimulated uptake in normal versus insulinresistant cells. Exposure to penta-and hexapeptides in- Cells were exposed to 1 mg/ml YGAGA, AGAGY, YGAGAG and GAGAGY for 24 h. Deoxyglucose uptake was assessed as described in Fig. 1 . Data represent meansϮS.D. ofcreased insulin-stimulated uptake in normal cells to a similar degree. In contrast, in insulin-resistant cells, hexapeptides were much more effective than pentapeptides in increasing insulin-stimulated uptake. Hexapeptides almost completely blocked the loss of glucose uptake in response to chronic insulin exposure (more than 85% of insulin-stimulated glucose uptake in control cells were recovered) whereas pentapeptides had very low effects. The insulin-glucose uptake was enhanced by 43.8Ϯ3.8% and 59.3Ϯ4.2% in YGAGAG-and GAGAGY-treated insulin-resistant cells, respectively, over control cells. In subsequent experiments in which the effect of hexapeptide was tested, GAGAGY was employed preferentially because it showed relatively higher activity than YGAGAG both in normal and insulin-resistant cells.
To determine if the PI 3-K is involved in the GAGAGY-induced sensitization, we utilized the PI 3-K inhibitor, wortmannin. As shown in Fig. 3 , acute wortmannin blocked insulin-stimulated glucose uptake in both control and GAGAGY-treated cells. This suggests that the GAGAGYsensitizing activity is PI 3-K-dependent. If the GAGAGY-dependent activity was PI 3-K-independent, then the difference between insulin stimulation and GAGAGY-induced enhancement of that activity was to remain. We also examined whether Akt phosphorylation, a known PI 3-K signaling event, was involved. As shown in Fig. 4 , exposure of cells to GAGAGY led to significant augmentation of insulin-dependent Akt phosphorylation on both Thr 308 and Ser 473 without affecting the total pool. This observation agrees with the inhibition of GAGAGY-induced insulin-stimulated glucose uptake by wortmannin.
Effect of GAGAGY on The Translocation and Expression of GLUT4 We next focused on GLUT4 translocation which is a result of PI 3-K signaling pathway and ultimately leads to the increase of glucose uptake. To determine the effect of GAGAGY on GLUT4 translocation, we have analyzed content in specific membrane fractions by immunoblotting. Through the analysis, the effect of GAGAGY on the expression of GLUT4 also could be examined. To address the issue of the insulin sensitizing effect, cells were treated chronically with GAGAGY and then stimulated acutely with insulin (Fig. 5) . These data show that GAGAGY increases the relative amount of GLUT4 in the plasma membrane (the PM fraction) both in the absence and presence of insulin. As observed, insulin stimulated the translocation of GLUT4 from the low density microsome (LDM) fraction (the translocatable pool) into the PM fraction more in GAGAGY-treated cells than in not-treated cells, i.e., the reduction in GLUT4 in the LDM fraction was higher in the presence of insulin in GAGAGY-treated cells. This is consistent with an increase in insulin sensitivity as noted in the glucose uptake experiments above. However, the amounts of GLUT4 in the high density microsome (HDM) fraction (the biosynthetic pool) were relatively constant, indicating that GAGAGY has no effect on GLUT4 expression.
DISCUSSION
Previously reported data describe that fibroin preparations including fibroin protein, acid hydrolysate of fibroin, and a fibroin peptide fraction enhance insulin sensitivity and glucose metabolism in 3T3-L1 adipocytes. 17) In these studies, we have initially tested the effect of enzymatic hydrolysates of fibroin prepared by proteolysis using trypsin, pepsin, chy- Fig. 3 . Effect of Wortmannin on GAGAGY-Induced Insulin-Stimulated Glucose Uptake Cells were exposed to 1 mg/ml GAGAGY for 24 h, then rinsed in KRP and incubated with or without 100 nM wortmannin for 10 min. Insulin (100 nM) was added or not for an additional 10 min before deoxyglucose uptake was assessed. Data represent meansϮS.D. of 3 independent experiments. * pϽ0.01 compared to insulin-stimulated glucose uptake value of GAGAGY-treated cells.
Fig. 4. Effect of GAGAGY on Insulin-Dependent Akt Phosphorylation
Cells were treated with 1 mg/ml GAGAGY for 12 h. Cells were rinsed in KRP for 10 min and then insulin (100 nM) was added for an additional 10 min. Cells were then washed and extracted for Akt. Equal protein was analyzed by SDS/PAGE-Western blot to measure total Akt, p-Akt (Thr308), and p-Akt (Ser473). Immunoblots are representative of 3 independent experiments. Data represent meansϮS.D. of 3 independent experiments. * ,# pϽ0.05 compared to relative intensity values of p-Akt (Thr308) and p-Akt (Ser473) in control (GAGAGY-untreated) cells, respectively.
Fig. 5. Effect of GAGAGY on Insulin-Stimulated GLUT4 Translocation
Cells were treated with 1 mg/ml GAGAGY for 12 h. Cells were rinsed in KRP for 10 min and then insulin (100 nM) was added for an additional 10 min. Subcellular fractions were prepared and GLUT4 proteins were resolved by SDS-PAGE and analyzed by Western blotting. Immunoblots are representative of 3 independent experiments. Data represent meansϮS.D. of 3 independent experiments. * pϽ0.05 compared to relative intensity value of GLUT4 in control (GAGAGY-untreated) cells. motrypsin or a bacterial protease (subtilisin) on glucose transport in 3T3-L1 cells. Interestingly, the chymotryptic and peptic hydrolysates showed significantly higher activities of enhancing insulin-stimulated glucose uptake than other types of hydrolysate. Among proteases, chymotrypsin and pepsin catalyze the cleavage of only peptide bonds adjacent to a phenylalanine, a tryptophan, or a tyrosine residue, regardless of the length or amino acid sequence of the chain. Fibroin protein is composed of 45.9% Gly, 30.3% Ala, 12.1% Ser, 5.3% Tyr, 1.8% Val, and only 4.7% of the other 15 amino acids, 12, 25) and most of the sequence is low-complexity and forms a Gly-X dipeptide motif covering 94% of the sequences; X is Ala in 64%, Ser in 22% and Tyr in 10% of the repeats. From the facts together, we could surmise that the chymotryptic and peptic hydrolysates contain higher amount of peptides with tyrosine residues at their ends.
It provided us a motivation to examine the bioactivities of synthetic peptides as deduced from fibroin sequence. The rationale for synthesizing peptides came from information indicating that the heavy chain of Bombyx mori silk fibroin is a 5263-residue (391-kDa) polypeptide comprising 12 lowcomplexity domains made up of two types of repetitive peptides, GAGAGS (433 copies) and GAGAGY (120 copies). 12) There are also four other frequently observed repetitive units including GAGYGA (39 copies), GAGAGA (27 copies), GAGVGA (27 copies) and GAGVGY (10 copies). Any of these peptides may arise during fibroin hydrolysis and may individually or in combination, have insulin-sensitizing activity in 3T3-L1 cells. Thus we tested these peptides in glucose transport assay in comparison to the enzymatic hydrolysates of fibroin. Surprisingly, our data show that GAGAGY and GAGVGY have discriminatively higher activities than other four peptides. Of note is the presence of a carboxyl-terminal tyrosine residue (Y) in GAGAGY and GAGYGY. Also to our surprise, this is consistent with the data showing significantly higher activities of the chymotryptic and peptic hydrolysates of fibroin than that of other hydrolysates. Thus it was hypothesized that a terminal tyrosine residue is responsible for higher insulin-sensitizing activities caused by treatment of the peptides.
To prove the action of terminal tyrosine, we compared the activities of tri-, tetra-, penta-and hexapeptides with or without terminal tyrosine residue, all of which appear repeatedly in fibroin. As expected, we observed that peptides with terminal tyrosine had more robust effects than those without terminal tyrosine in same length. From the data showing the higher activity of longer peptides and the action of terminal tyrosine, it is suggested that the peptides may exhibit an insulin-like activity on 3T3-L1 adipocytes. Although we did not measure the insulin binding activity of cells in the presence or absence of peptides, we guess that a longer peptide with terminal tyrosine might stimulate cells by itself or enhance the binding of insulin to its receptor.
We also found that hexapeptides with terminal tyrosine, GAGAGY and YGAGAG, are discriminative from pentapeptides, AGAGY and YGAGA in blocking the development of insulin resistance. To test the development of insulin resistance, we employed an insulin-resistant model system of 3T3-L1 adipocytes. In our hands, chronic exposure to low concentrations of insulin (10 nM) induced a state of insulin resistance, which was indicated by a 50% decrease in acute-insulin-stimulated glucose transport. It has been reported that, in this model system, both of the total pool of GLUT4 transporters and their number in the plasma membrane are reduced. 21) In these studies, while all 4 peptides augmented insulin-stimulated uptake in normal cells to similar degrees, to our surprise, the enhancing effect in insulin-resistant cells was shown by only hexapeptides, GAGAGY and YGAGAG. Our data show that the effect of GAGAGY, in particular, was so remarkable. The insulin-stimulated uptake in GAGAGYtreated insulin-resistant cells recovered up to 92%-level of that in control normal cells. These findings led us to investigate the mechanism by which GAGAGY exerts its effect. In defining the mechanism that underlies the effect of GAGAGY on insulin-stimulated glucose uptake, we focused on PI 3-K pathway.
To assure that the classical insulin signaling pathway was a target of GAGAGY action, we tested the role of PI 3-K with the PI 3-K inhibitor wortmannin in both control and GAGAGY-treated cells. As shown by others, 26, 27) insulinstimulated glucose uptake is completely blocked by wortmannin. Our data show that wortmannin blocked the increase in glucose uptake stimulated by the acute addition of insulin in either the presence or absence of GAGAGY. This wortmannin-induced loss of GAGAGY action may reflect a loss of GAGAGY-stimulated PI 3-K signaling, which may eliminate the GAGAGY-induced insulin-stimulated glucose uptake. Akt also appears to participate in the insulin-signaling PI 3-K pathway by phosphorylating glycogen synthase kinase-328) and stimulating GLUT4 translocation. 7) We found that exposure of cells to GAGAGY resulted in significantly increased Ser and Thr phosphorylation of Akt. These results also suggest that GAGAGY enhances PI 3-K dependent path.
Activation of PI 3-K is essential for insulin-stimulated GLUT4 translocation to the plasma membrane. [29] [30] [31] As expected, data from this study show a significant increase in GLUT4 in the PM fraction and a simultaneous decrease in the LDM fraction in response to GAGAGY, without change of GLUT4 amount in the biosynthetic pool represented by HDM fraction which contains ER and Golgi. This indicates that GAGAGY activates the translocation of GLUT4 from the intracellular pool to the cell surface, which does not appear to result from increased synthesis. This suggests that GAGAGY-mobilized pool of GLUT4 incorporates into the plasma membrane with insulin stimulation and that this event results in an amplified insulin effect. Taken together with the results of wortmannin inhibition and Atk activation, it is indicated that GAGAGY sensitizes PI 3-K-dependent insulin signaling, followed by increase of insulin's effect on GLUT4 translocation, ultimately leading to increased insulin-stimulated glucose uptake.
Required for the translocation of GLUT4 is the stimulation of at least two discrete signaling paths, PI 3-K and TC10 pathways.
3) Although we did not examine the effect of GAGAGY on TC10 pathway, in our hands, the GAGAGY-induced increase in GLUT4 translocation is at least linked to the activation of PI 3-K dependent path. We are left to investigate the mechanisms underlying the enhancing effect of GAGAGY in detail.
Our findings suggest that the GAGAGY peptide can display beneficial effects in the treatment of diabetes based on its enhancing effect on insulin sensitivity and interfering ac-tion with the development of insulin resistance. A number of current therapeutic agents for type 2 diabetes appear to function in this way. 9) For example, metformin, a biguanide, acts to reduce hepatic glucose production and appears to improve insulin sensitivity in muscle and liver and to increase the translocation of glucose transporters to the cell surface. 32) Although rare, one of the side effects of metformin is lactic acidosis, a potentially fatal condition. Thiazolidinediones (TZDs) also target muscle and fat to enhance insulin action, acting as agonists for the nuclear transcription factor, peroxisomal proliferator-activated receptor-g (PPARg). 33) Effects include increased phosphorylation of insulin receptor, IRS-1, and Akt. In addition, TZDs increase the expression of GLUT4 in adipose tissue 34) and enhances GLUT4 translocation in muscle. 35) However, troglitazone has been removed from the market because of reports of severe liver injury, several of which have proved fatal. Although newer TZDs (rosiglitazone and pioglitazone) have a much lower incidence of this side effect, of particular concern is the tendency for TZD treatments to enhance weight gain. Obviously, there is room for new drug development and newer approaches are desperately needed. 9) Our previous studies showed that the hallmarks of action of fibroin peptides are not consistent with TZDs' mechanism. 17) Fibroin peptides such as peptide mixtures of hydrolyzed fibroin or peptides derived from fibroin including GAGAGY, GAGVGY, YGAGVG and YGAGAG can be a new strategy for development of anti-diabetic peptide drugs. Although we are now just exploring the detailed molecular mechanism underlying the effect of GAGAGY, further studies may lead to new therapeutic approaches in the treatment and/or prevention of type 2 diabetes.
